Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL2180179 |
---|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
P2X4/P2X purinoceptor 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2104] [GtoPdb: 481] [UniProtKB: Q99571] | ||||||||
ChEMBL | Antagonist activity at human P2X4R transfected in HEK293 cells assessed as inhibition of ATP-mediated calcium influx measured after 10 mins by YOPRO-1 dye uptake assay | B | 5.04 | pIC50 | 9200 | nM | IC50 | J Nat Prod (2019) 82: 2559-2567 [PMID:31532206] |
ChEMBL | Antagonist activity at human P2X4R transfected in 1321N1 cells assessed as inhibition of ATP-mediated calcium influx measured after 10 mins by Fura-2AM assay | B | 5.24 | pIC50 | 5700 | nM | IC50 | J Nat Prod (2019) 82: 2559-2567 [PMID:31532206] |
ChEMBL | Antagonist activity at P2X4R (unknown origin) expressed in 1321N1 cells | B | 5.28 | pIC50 | 5200 | nM | IC50 | J Med Chem (2022) 65: 13967-13987 [PMID:36150180] |
ChEMBL | Antagonist activity at human P2X4 receptor expressed in HEK cells by Qpatch method | B | 5.4 | pIC50 | 3990 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
ChEMBL | Antagonist activity at human P2X4 receptor expressed in HEK cells assessed as reduction in ATP induced calcium influx | B | 5.43 | pIC50 | 3710 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
ChEMBL | Antagonist activity at human P2X4R transfected in HEK293 cells | B | 5.92 | pIC50 | 1200 | nM | IC50 | J Nat Prod (2019) 82: 2559-2567 [PMID:31532206] |
GtoPdb | - | - | 6 | pIC50 | - | - | - |
Mol Pharmacol (2013) 83: 759-69 [PMID:23253448]; Neuropharmacology (2016) 104: 31-49 [PMID:26686393] |
ChEMBL | Antagonist activity at human P2X4 receptor expressed in CHO cells assessed as reduction in ATP induced calcium influx | B | 6.3 | pIC50 | 500 | nM | IC50 | J Med Chem (2019) 62: 11194-11217 [PMID:31746599] |
ChEMBL | Antagonist activity at human P2X4 receptor expressed in CHO cells | B | 6.3 | pIC50 | 500 | nM | IC50 | Eur J Med Chem (2018) 151: 462-481 [PMID:29649742] |
ChEMBL | Antagonist activity at human P2X4 receptor expressed in CHO cells assessed as inhibition of ATP-induced calcium influx | B | 6.3 | pIC50 | 500 | nM | IC50 | J Med Chem (2016) 59: 7410-7430 [PMID:27427902] |
ChEMBL | Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced cytosolic calcium influx compound preincubated for 30 mins before ATP treatment by Fluo-4 AM fluorescence method | F | 6.3 | pIC50 | 500 | nM | IC50 | J Med Chem (2012) 55: 9576-9588 [PMID:23075067] |
ChEMBL | Antagonist activity at human P2X4 receptor expressed in 1321N1 cells assessed as inhibition of ATP-induced calcium flux measured for 30 secs at 0.4 secs intervals by Flou-4-AM dye based fluorescence assay | B | 6.46 | pIC50 | 350 | nM | IC50 | Eur J Med Chem (2018) 151: 462-481 [PMID:29649742] |
ChEMBL | Antagonist activity at human P2X4 receptor expressed in human 1321N1 cells assessed as inhibition of ATP-induced calcium influx preincubated for 30 mins prior to ATP-stimulation by calcium influx assay | B | 6.46 | pIC50 | 348 | nM | IC50 | J Med Chem (2016) 59: 7410-7430 [PMID:27427902] |
P2X4/P2X purinoceptor 4 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2818] [GtoPdb: 481] [UniProtKB: P51577] | ||||||||
ChEMBL | Antagonist activity at rat P2X4R expressed in HEK293 cells preincubated for 2 mins followed by ATP addition and measured after 4 mins | B | 6.12 | pIC50 | 750 | nM | IC50 | J Med Chem (2022) 65: 13967-13987 [PMID:36150180] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]